• Return to Headlines

Shares of Dexcom Rise Above Previous 52-Week High

By Shiri Gupta

Dexcom (NASDAQ:DXCM) traded at a new 52-week high today of $123.48. This new high was reached on above average trading volume as 2.3 million shares traded hands, while the average 30-day volume is approximately 865,000 shares.

Dexcom (NASDAQ:DXCM) defies analysts with a current price ($120.42) 32.5% above its average consensus price target of $81.25. The stock should discover initial support at its 50-day moving average (MA) of $96.70 and subsequent support at its 200-day MA of $70.19.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

In the past 52 weeks, Dexcom share prices have been bracketed by a low of $42.62 and a high of $123.48 and are now at $120.42, 183% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has advanced 0.5%.

SmarTrend is monitoring the recent change of momentum in Dexcom. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Dexcom in search of a potential trend change.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM